NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

You state:

When the company started touting method A vs method B, I called it total BS. Now the company doesn't even bring it up anymore. I still think that direct was a good try, but one has to accept that it was a failure. Their direction with their p2 IMO will be a waste of time and resources

Why would they still talk about methods A and B. They demonstrated that one method worked and the other didn't, so they abandoned the ineffective method. Have you seen the charts NWBO presented at the Phaciliate Immunotherapy World Forum in January? Look at chart-8 on DCVAX-Direct Ph-1 status update. 12 out of the 36 patents are still alive > 14 months up to 26 months. These are patents with inoperable Sarcoma, Pancreas, Bladder, Melenoma, and Gall Blader Cancers. If Direct works like L works where it is effectively a cure for a subset of the patients, the Mesenchymal subgroup patients we may be seeing the same kind of thing going on for Direct. It is still early, too early to conclude it is ineffective. Lets see if the bulk of the 14 of 26 patients are still alive at 3 and 4 and 5 years, Then we'll know.